Today: 19 May 2026
Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?
12 November 2025
2 mins read

Oracle Stock Today (Nov 12, 2025): ORCL Slips ~4% as Buy‑the‑Dip Calls Collide With Ongoing Pullback

Byline: Nov 12, 2025


Key Takeaways

  • Price action: As of 18:41 UTC, Oracle (NYSE: ORCL) trades at $227.02, down about 3.9% intraday after opening at $236.68. Today’s range: $226.23–$238.39; volume ~14.9M shares.
  • Yesterday’s finish: ORCL closed at $236.15 in the prior session.
  • Fresh analyst color:Mizuho reiterated an Outperform and framed the latest weakness as a buying opportunity, maintaining a $400 price target.
  • Context this week: Financing headlines around a $18B project‑finance loan tied to an Oracle‑linked data center campus have kept the company’s infrastructure build‑out in focus.

Oracle Stock Today: What’s Moving ORCL on November 12

1) Risk‑off in Oracle despite upbeat brokerage tone
Shares are lower midday even as Mizuho tells clients the latest pullback is an opportunity, sticking with an Outperform/$400 view. The note underscores confidence in Oracle’s cloud and AI pipeline despite near‑term volatility.

2) Tape and technicals doing the talking
Short‑term momentum remains soft: ORCL is trading below yesterday’s close and near the session low, reflecting continued digestion after a powerful 2025 run. Intraday stats—$227.02 last; $226.23–$238.39 range; $236.68 open—highlight the sellers’ advantage today.

3) Headlines amplifying the ‘pullback’ narrative
Media coverage this morning emphasized the stock’s recent slide from autumn peaks, reinforcing a cautious near‑term tone among traders even as long‑only analysts stay constructive.

4) Flows and filings: small adds, steady interest
Smaller advisers reported incremental buying in new 13F disclosures—Kelleher Financial Advisors disclosed a new 1,278‑share position, while Ironwood Investment Counsel boosted its stake—signaling select accumulation on weakness. These are minor in size but directionally supportive.


Broader Context: What Else Investors Are Watching This Week

  • Data‑center capital build‑out: A ~$18B bank loan package for a New Mexico data‑center campus tied to Oracle (via partner reporting) illustrates how capital‑intensive the company’s AI‑era infrastructure ambitions are—and why investors parse every financing headline for clues on capacity and margins.
  • Management and strategy coverage: Recent reporting has also spotlighted governance and leadership dynamics around Oracle’s cloud push and scale‑up—another theme institutions cite when sizing long‑term risk/reward.

Near‑Term Catalysts

  • Earnings window: Oracle’s fiscal Q2 (FY26) update is slated for mid‑December, a key checkpoint for cloud bookings, backlog conversion, and capex pacing. Several third‑party calendars currently place the event in the week of December 8. Expect guidance and commentary on AI infrastructure demand, multicloud wins, and margin cadence.
  • Cloud growth roadmap: Management has telegraphed aggressive cloud‑infrastructure expansion targets through the decade; investors will look for consistency between those ambitions and the near‑term numbers next month.

Today’s ORCL Snapshot (Intraday)

  • Last: $227.02
  • Change (vs. prior close): –$9.13 (~–3.9%)
  • Open / Day Range: $236.68 / $226.23–$238.39
  • Volume (approx.): 14.9M
  • Prior Close (Nov 11): $236.15
    Data as of 18:41 UTC, Nov 12, 2025.

Bottom Line

Oracle’s stock is under pressure today even as bullish brokerage commentary highlights long‑term tailwinds from AI‑driven cloud demand. With financing activity and infrastructure scale‑up in the headlines this week—and earnings due in mid‑December—today’s drawdown looks like typical “pre‑catalyst” positioning. Short‑term volatility aside, the next print will need to validate backlog conversion, capex discipline, and margin trajectory to reset the near‑term narrative.

This article is for information only and does not constitute investment advice. Always do your own research and consider speaking with a licensed financial advisor before making trading decisions.

Sources: Intraday pricing/volume from market data; prior close and session summary from Yahoo Finance; Mizuho note coverage from Yahoo Finance; financing headlines from Reuters; leadership/strategy context from Bloomberg; earnings timing from Oracle Investor Relations and Nasdaq’s earnings calendar.

Stock Market Today

  • UK Shares Flat as Labor Market Weakens; IG Group Shares Surge
    May 19, 2026, 12:34 PM EDT. London's FTSE 100 closed modestly higher by 0.07% as investors digested softer UK labor market data. The unemployment rate rose slightly to 5%, exceeding expectations, while regular pay growth slowed to 3.4%, the weakest since 2020. These figures suggest reduced economic sensitivity to recent energy price shocks and raise doubts about upcoming Bank of England interest rate hikes, with the next decision partly hinged on upcoming inflation data. In corporate news, IG Group shares jumped 10.53% after raising its 2026 revenue growth forecast to 10-15%. Diploma also upgraded its fiscal outlook, boosting expectations for organic growth and profitability, supported by solid first-half results and stronger dividends. This marks renewed investor confidence amid mixed economic signals.

Latest articles

Why Constellation Software Stock Is Jumping While Canada’s Market Slips

Why Constellation Software Stock Is Jumping While Canada’s Market Slips

19 May 2026
Toronto, May 19, 2026, 12:05 (EDT) Constellation Software shares jumped on Tuesday, rising 9.5% to C$2,860.21 at 11:40 a.m. in Toronto, as investors bought back into one of Canada’s biggest software names while the broader S&P/TSX composite edged lower. Google Finance showed the stock opening at C$2,625.00 and touching C$2,880.35 intraday. The move matters because trading resumed after Monday’s Victoria Day closure, giving investors a fresh chance to react to last week’s earnings, analyst calls and the broader debate over whether artificial intelligence will weaken or help the company’s portfolio of niche software businesses. TMX said Canadian exchanges would reopen
InMed Soars 100% on $290M Migraine Deal

InMed Soars 100% on $290M Migraine Deal

19 May 2026
InMed Pharmaceuticals shares jumped 108.6% to $1.42 after agreeing to merge with Mentari Therapeutics in an all-stock deal, shifting focus to migraine prevention. The combined company will operate as Mentari, backed by a $290 million private placement, with InMed shareholders owning about 1.51%. Nearly 69.6 million shares traded, and InMed’s market value reached $5.7 million.
Anthropic Brings on OpenAI Co-Founder Andrej Karpathy

Anthropic Brings on OpenAI Co-Founder Andrej Karpathy

19 May 2026
Anthropic has hired Andrej Karpathy, a founding OpenAI member and former Tesla AI executive, to join its pre-training team. Karpathy will work under Nick Joseph and lead efforts to use Claude to speed pre-training research. He starts this week. Anthropic has also added Chris Rohlf, a cybersecurity specialist, to its frontier red team.

Popular

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Google Stock Today (GOOGL, GOOG) — Nov. 12, 2025: Waymo Hits Freeways, New EU Probe Looms, “Private AI Compute” Debuts

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook
Next Story

Pfizer (PFE) Stock Today, November 12, 2025: Shares Nudge Higher as Jefferies Webcast Set, Metsera Deal Stays in Focus

Go toTop